Institutional investors hold a majority ownership of THOR through the 94.29% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended December 2013, these large investors purchased a net $1.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 1.7 Million shares of Thoratec Corp
BLACKROCK FUND ADVISORS Bought 957.9 Thousand shares of Thoratec Corp
STATE STREET GLOBAL ADVISORS LTD... Bought 508.6 Thousand shares of Thoratec Corp